Question 1

What does Corridor Pharmaceuticals do?

Accepted Answer

Corridor Pharmaceuticals is a platform-based pulmonary and critical care company developing novel therapeutics for elevated arginase levels.

Question 2

In what sectors does Corridor Pharmaceuticals operate?

Accepted Answer

Corridor Pharmaceuticals operates in Biotechnology, Health Care, Therapeutics.

Question 3

How many companies has Corridor Pharmaceuticals acquired?

Accepted Answer

Corridor Pharmaceuticals has made 1 acquisitions between 2010-2010.

Question 4

What companies are owned by Corridor Pharmaceuticals?

Accepted Answer

Companies acquired by Corridor Pharmaceuticals include Immune Control.

Question 5

What was Corridor Pharmaceuticals's first acquisition?

Accepted Answer

Corridor Pharmaceuticals's first recorded acquisition was Immune Control in 2010.

Question 6

What was Corridor Pharmaceuticals's most recent acquisition?

Accepted Answer

Corridor Pharmaceuticals's most recent acquisition is Immune Control, announced June 2010.

Question 7

What sectors does Corridor Pharmaceuticals usually acquire in?

Accepted Answer

Corridor Pharmaceuticals most frequently acquires companies in Health Care, Health Diagnostics, Medical.

Question 8

In which sector has Corridor Pharmaceuticals made the most acquisitions?

Accepted Answer

Corridor Pharmaceuticals has made the most acquisitions in the Health Care sector.

Question 9

In which year did Corridor Pharmaceuticals make the most acquisitions?

Accepted Answer

Corridor Pharmaceuticals made the most acquisitions in 2010, with 1 deal.

Corridor Pharmaceuticals

Company Details